Indeed, in ovarian cancer, the constitutive production of IL-6 by cancer cells has been strongly demonstrated [88], as wells as IL-6 ability to promote tumor growth and progression through autocrine and paracrine actions [89, 90] and to cause specific immune and metabolic alteration that impact prognosis [91]. Here, IL6 is linked to ovarian cancer.